Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Kell expression on myeloid progenitor cells.

T Wagner1, G Lanzer, K Geissler

  • 1Department of Blood Group Serology and Transfusion Medicine, University Hospital Graz, Austria. thomas.wagner@kfunigraz.ac.at

Leukemia & Lymphoma
|May 11, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[German Guideline for Idiopathic Pulmonary Fibrosis].

Pneumologie (Stuttgart, Germany)·2020
Same author

[German Guideline for Idiopathic Pulmonary Fibrosis].

Pneumologie (Stuttgart, Germany)·2020
Same author

Laryngo- rhino- otologie·2018
Same author

Laryngo- rhino- otologie·2018
Same author

Differential regulation of PD-1 and its ligands in allergic asthma.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2017
Same author

[IgE and Anti-IgE in Asthma: A Chequered History].

Pneumologie (Stuttgart, Germany)·2017
Same journal

CPX‑351 vs. FLAG‑ida in patients with high-risk AML/MDS and MDS-related gene mutations: a subgroup analysis of the UK NCRI AML19 trial.

Leukemia & lymphoma·2026
Same journal

Specialist palliative care access and end-of-life hospitalizations in acute leukemia: a nationwide register study.

Leukemia & lymphoma·2026
Same journal

D-VRD vs. D-KRD induction in transplant-eligible multiple myeloma: a real-world comparison.

Leukemia & lymphoma·2026
Same journal

T-box factor EOMES is part of an aberrant network in Hodgkin lymphoma.

Leukemia & lymphoma·2026
Same journal

Overall survival of patients with chronic lymphocytic leukemia treated with venetoclax-obinutuzumab compared to age- and sex-matched general population.

Leukemia & lymphoma·2026
Same journal

Hypertension and time to treatment failure with acalabrutinib and ibrutinib in treatment-naïve CLL/SLL.

Leukemia & lymphoma·2026
See all related articles

Kell antigens, crucial for blood groups, are expressed on more than just red blood cells. Research shows Kell antibodies also impact myeloid and megakaryocyte cell growth, expanding our understanding of Kell

Area of Science:

  • Hematology
  • Immunology
  • Genetics

Background:

  • The Kell blood group system, comprising 22 antigens including Kell (K, K1) and cellano (k, K2), is determined by alleles on chromosome 7.
  • Kell antigens are produced by a 93-kDa transmembrane glycoprotein with homology to zinc endopeptidases.
  • Anti-Kell antibodies are known to suppress fetal erythropoiesis.

Purpose of the Study:

  • To investigate the broader effects of anti-Kell antibodies beyond erythropoiesis.
  • To determine if Kell antigens are expressed on other hematopoietic cells.
  • To explore the impact of anti-Kell antibodies on myelopoiesis and megakaryopoiesis.

Main Methods:

  • Analysis of fetal thrombocytopenia in hemolytic disease of the newborn (HDN) cases linked to anti-K antibodies.

Related Experiment Videos

  • Assessment of the inhibitory effects of Kell-related antibodies on colony-forming unit-megakaryocyte (CFU-MK) growth.
  • Evaluation of the impact of anti-Kell antibodies on burst-forming unit-erythroid (BFU-E) and colony-forming unit-granulocyte-macrophage (CFU-GM) colony formation from peripheral blood mononuclear cells (MNCs).

    • Main Results:

    • Anti-K antibodies were linked to significant fetal thrombocytopenia, revealing an inhibitory effect on CFU-MK growth.
    • Anti-Kell antibodies inhibited BFU-E growth.
    • Anti-Kell, anti-cellano, and anti-Kp(b) antibodies inhibited CFU-GM colony formation, even from antigen-positive MNCs.

    Conclusions:

    • Kell antigens are expressed on a wider range of hematopoietic cells than previously recognized.
    • Kell-related antibodies can impact myelopoiesis and megakaryopoiesis, not solely erythropoiesis.
    • These findings necessitate a re-evaluation of the Kell blood group system's role in hematopoiesis and related disorders.